Sanderling IV Biomedical Co-Investment Fund, L.P.
A co-investment vehicle for specific deals, not a commingled fund.
Nothing material in the last 365 days.
- Vintage
- unknownno dated first sale or first report yet
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- unknownwhat may be sold, not what was raised; file 021-1040901, sworn by the adviser or filed under this vehicle
- Form D sold
- unknown
- First sale
- unknown
- Reported GAV
- $207,505on the Form ADV filed Apr 3, 2023; the fund's assets, never its size or dry powder
- Owners (ADV)
- 5
- Reported on ADV
- Mar 30, 2012 to Apr 3, 2023no longer reported: wound down, transferred or renamed
LifecycleWound down
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 30, 2012 | Venture Capital Fund | $2.9M | 4 | $1 | 1% | no | |
| Oct 25, 2012 | Venture Capital Fund | $2.9M | 4 | $1 | 1% | no | |
| Mar 27, 2013 | Venture Capital Fund | $1.1M | 4 | $1 | 1% | no | |
| Mar 28, 2014 | Venture Capital Fund | $648,398 | 4 | $1 | 1% | no | |
| Mar 26, 2015 | Venture Capital Fund | $475,691 | 4 | $1 | 1% | no | |
| Mar 21, 2016 | Venture Capital Fund | $587,422 | 4 | $1 | 1% | no | |
| Mar 21, 2017 | Venture Capital Fund | $149,248 | 4 | $1 | 1% | no | |
| Jan 29, 2018 | Venture Capital Fund | $149,248 | 4 | $1 | 1% | yes | |
| Feb 5, 2018 | Venture Capital Fund | $149,248 | 4 | $1 | 1% | yes | |
| Apr 2, 2018 | Venture Capital Fund | $470,372 | 4 | $1 | 1% | no | |
| Mar 28, 2019 | Venture Capital Fund | $269,088 | 4 | $1 | 1% | no | |
| Apr 29, 2020 | Venture Capital Fund | $251,815 | 4 | $1 | 1% | no | |
| Mar 31, 2021 | Venture Capital Fund | $243,845 | 4 | $1 | 1% | no | |
| Apr 4, 2022 | Venture Capital Fund | $220,294 | 5 | $1 | 1% | no | |
| Apr 3, 2023 | Venture Capital Fund | $207,505 | 5 | $1 | 1% | no |
- AdministratorGREENOUGH CONSULTING GROUP · BURLINGAME, California, United StatesForm ADV filed Apr 3, 2023 sec.gov
- CustodianSilicon Valley Bank · SANTA CLARA, California, United StatesForm ADV filed Apr 3, 2023 sec.gov
- CustodianRBC CAPITAL MARKETS, LLC · SAN FRANCISCO, California, United StatesForm ADV filed Apr 3, 2023 sec.gov
- Mar 30, 2024Sanderling IV Biomedical Co-Investment Fund, L.P. no longer reported on Form ADV by Sanderling Management Company, LLCFund no longer reported Inference Form ADV
- Apr 29, 2020Administrator changed: GREENOUGH CONSULTING GROUP replaced HC GLOBAL FUND SERVICES, LLC, first reported on the Form ADV filed April 29, 2020 (previous filing March 28, 2019)Administrator changed Fact Form ADV
- Mar 30, 2012Sanderling IV Biomedical Co-Investment Fund, L.P. first reported on Form ADV by Sanderling Management Company, LLC (Venture Capital Fund), GAV $2,935,536Fund first reported on Form ADV Fact Form ADV
Every observation on this vehicle
Relationships across DFX
on 1 other DFX graph
Sanderling IV Biomedical Co-Investment Fund, L.P. is the same institution as 1 record in RIA and Wealth.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Record history
- Fund dropped from ADV2024-03-30source on record
- Fund first reported on ADV2012-03-30source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.